Skip to main content
Journal cover image

Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography.

Publication ,  Journal Article
St-Amant, P; Foster, W; Froment, M-A; Aubin, S; Lavallée, M-C; Beaulieu, L
Published in: Brachytherapy
2017

PURPOSE: To evaluate if the addition of 3D transabdominal ultrasound (3DTAUS) imaging to computed tomography (CT) can improve treatment planning in 3D adaptive brachytherapy when compared with CT-based planning alone, resulting in treatment plans closer to the ones obtained using magnetic resonance imaging (MRI)-based planning. METHODS AND MATERIALS: Five patients with cervical cancer undergoing brachytherapy underwent three imaging modalities: MRI, CT, and CT-3DTAUS. Volumes were delineated by a radiation oncologist and treatment plans were optimized on each imaging modality. To compare treatment plans, the dwell times optimized on MRI were transferred on CT and CT-3DTAUS images and dose parameters were reported on volumes of the receiving imaging modality. The plans optimized on CT and CT-3DTAUS were also copied and evaluated on MRI images. RESULTS: Treatment plans optimized and evaluated on the same imaging modalities were clinically acceptable but statistically different (p < 0.05) from one another. MR-based plans had the highest target coverage (98%) and CT-based plans the lowest (93%). For all treatment plans evaluated on MRI, the target coverage was equivalent. However, a decrease in target coverage (V100) was observed when MR-based plans were applied on CT-3DTAUS (6%) and CT (13%) with p < 0.05. An increase in the rectum/sigmoid dose (D2cc) was observed with both CT-3DTAUS-based (0.6 Gy) and CT-based planning (1 Gy) when compared with MR-based plans, whereas bladder dose stayed similar. CONCLUSIONS: When compared with CT-based planning, the addition of 3DTAUS to CT results in treatment plans closer to MR-based planning. Its use reduces the high-risk clinical target volume overestimation typically observed on CT, improving coverage of the target volume while reducing dose to the organs at risk.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Brachytherapy

DOI

EISSN

1873-1449

Publication Date

2017

Volume

16

Issue

4

Start / End Page

847 / 854

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
St-Amant, P., Foster, W., Froment, M.-A., Aubin, S., Lavallée, M.-C., & Beaulieu, L. (2017). Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography. Brachytherapy, 16(4), 847–854. https://doi.org/10.1016/j.brachy.2017.03.006
St-Amant, Patricia, William Foster, Marie-Anne Froment, Sylviane Aubin, Marie-Claude Lavallée, and Luc Beaulieu. “Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography.Brachytherapy 16, no. 4 (2017): 847–54. https://doi.org/10.1016/j.brachy.2017.03.006.
St-Amant P, Foster W, Froment M-A, Aubin S, Lavallée M-C, Beaulieu L. Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography. Brachytherapy. 2017;16(4):847–54.
St-Amant, Patricia, et al. “Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography.Brachytherapy, vol. 16, no. 4, 2017, pp. 847–54. Pubmed, doi:10.1016/j.brachy.2017.03.006.
St-Amant P, Foster W, Froment M-A, Aubin S, Lavallée M-C, Beaulieu L. Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy: Comparison to magnetic resonance and computed tomography. Brachytherapy. 2017;16(4):847–854.
Journal cover image

Published In

Brachytherapy

DOI

EISSN

1873-1449

Publication Date

2017

Volume

16

Issue

4

Start / End Page

847 / 854

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences